Word: path
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...clear, windy day at Ohiri Field. Harvard dominated the run of play in the first half, taking the lead in the 34th minute when freshman forward Melanie Baskind’s skillful over-the shoulder volley split Yale’s back line and fell into the path of the speedy Sheeleigh. The sophomore saw her effort to slot the ball across the goal mouth deflect in for the game’s first goal, her second of the season.“I was just running down the flank...I was looking to put [the ball] back...
...first woman to conduct a mainstage production with the San Francisco Opera summarized her career path on Friday with a quote from Harvard Musician in Residence Isaiah A. Jackson III ’66: “You can’t plan the important things.” Hosted by the Harvard College Women’s Center and co-sponsored by the Office for the Arts at Harvard, Sara E. Jobin ’91 spoke with a group of students over lunch as part of the Alum-inating! program, a speaker series that brings a prominent alumna...
...second clip that lost either of their more able running mates the election. But just as last week’s show did nothing to advance the debate, except maybe exclude bracelets from future episodes, last night’s will do no more to put voters on the path toward making the right choice. The problem remains the same: a contest in which the rules are designed to save face will give us, the voters, nothing. The worse candidate cannot lose, and the best one will...
...twist to the campaign, giving the pragmatic voters of downscale Arapahoe County an unexpected and decisive role in November. In recent days, voters in that demographic have started to break toward Obama. "If John McCain does not carry the state of Colorado," says Obama campaign manager David Plouffe, "his path to the White House gets awfully darn narrow...
...more than $30 billion in sales last year. Its total sales reached $43 billion, generating profits of $10.5 billion. Nonetheless, the days of this trial-and-error approach may soon be over. All of Big Pharma is feeling pressure--from Wall Street, regulators and customers--to take a smarter path to discovery for that next blockbuster drug. And who wins vs. who is left behind is still very much...